Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications
Purpose To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Methods Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (...
Saved in:
Published in | International ophthalmology Vol. 43; no. 12; pp. 4585 - 4593 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.12.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.
Methods
Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.
Results
There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.
Conclusion
YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure. |
---|---|
AbstractList | Purpose
To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.
Methods
Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.
Results
There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.
Conclusion
YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure. To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits. There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3. YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure. To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.PURPOSETo evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.METHODSThirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.RESULTSThere were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.CONCLUSIONYAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure. PurposeTo evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.MethodsThirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.ResultsThere were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.ConclusionYAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure. |
Author | Liu, Jiannan Gu, Wei Zhao, Tingting Fan, Wenxue Peng, Shaomin Wang, Hao |
Author_xml | – sequence: 1 givenname: Jiannan surname: Liu fullname: Liu, Jiannan organization: Department of Ophthalmology, Dongguan Aier Eye Hospital Affiliated to Jinan University – sequence: 2 givenname: Hao surname: Wang fullname: Wang, Hao organization: Department of Ophthalmology, Hebei Eye Hospital – sequence: 3 givenname: Wei surname: Gu fullname: Gu, Wei organization: Department of Ophthalmology, Beijing Aier-Intech Eye Hospital – sequence: 4 givenname: Tingting surname: Zhao fullname: Zhao, Tingting organization: Department of Ophthalmology, Harbin Aier Eye Hospital – sequence: 5 givenname: Wenxue surname: Fan fullname: Fan, Wenxue organization: Department of Ophthalmology, Harbin Aier Eye Hospital – sequence: 6 givenname: Shaomin surname: Peng fullname: Peng, Shaomin email: pengshaomin@csu.edu.cn organization: Aier School of Ophthalmology, Central South University, Department of Ophthalmology, Harbin Aier Eye Hospital, Aier Retina Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37665493$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtv3SAQhVGUKM_-gSwqpG6ycTqAAbubKorykiJl0WbRFcXccUrka1ywr3T_fbhxmqRddIEA8c2Zw5wDst2HHgk5ZnDKAPTnxEDXvAAu8qpkVcAW2WdSi4IrAdvvznvkIKVHAKh1rXbJntBKybIW--TnN9viuKahpT_OrmhnE0a68mPE0K2TT7QNkfp-jDa4qbORjj6lCdMXans7E7l0CGkMA0Y7-hVSF5ZD512-hD4dkZ3Wdgk_vOyH5P7y4vv5dXF7d3VzfnZbuJKrsSixaoREp0umnON1LRoAK2S7sEqDXjQOLKqKLRqQspTAZNMyFG0phWykduKQfJ11h6lZ4sLhxnNnhuiXNq5NsN78_dL7X-YhrEweIi8FlFnh5EUhht_5i6NZ-uSw62yPYUqGVwoU01xCRj_9gz6GKeaBZKoGzhTXz9TH95ZevfyZfgb4DLgYUorYviIMzCZiM0dscsTmOWKzURVzUcpw_4Dxrfd_qp4AU0SqTQ |
Cites_doi | 10.1001/jamaophthalmol.2017.2477 10.1016/j.ajo.2011.01.005 10.1016/j.ajo.2014.10.006 10.5301/ejo.5000854 10.1016/j.ajo.2011.01.026 10.1038/sj.eye.6700026 10.3109/08820538.2010.518865 10.1111/j.1755-3768.2009.01682.x 10.1097/00006982-200202000-00001 10.1007/BF02143063 10.1016/j.ophtha.2020.10.026 10.1159/000477159 10.1007/s40123-021-00422-6 10.1111/ceo.13190 10.3109/02713688709034861 10.1097/IAE.0000000000000063 10.1136/bjophthalmol-2016-309005 10.3928/23258160-20181101-21 10.1001/jamaophthalmol.2017.2388 10.3928/23258160-20211014-02 10.1007/BF00417297 10.1177/11206721211008036 10.1097/IAE.0000000000000065 10.1007/s12325-020-01261-w 10.1136/bcr-2022-248937 10.1186/s12886-020-01428-7 10.1016/0167-5699(88)91200-5 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7QL 7T7 7TK 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. M0S M1P M7N P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1007/s10792-023-02858-0 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Technology Research Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-2630 |
EndPage | 4593 |
ExternalDocumentID | PMC10724304 37665493 10_1007_s10792_023_02858_0 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Aier Eye Hospital Group grantid: AM1901D1 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40E 53G 5GY 5QI 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8FW 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ ADHKG AGQPQ NPM PJZUB PPXIY 7QL 7T7 7TK 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c426t-4e8b35ec7416cc2993b00a35fda6707dbc0ae681db05545015bf1e3f4535b57c3 |
IEDL.DBID | C6C |
ISSN | 1573-2630 0165-5701 |
IngestDate | Thu Aug 21 18:37:56 EDT 2025 Fri Jul 11 11:07:14 EDT 2025 Fri Jul 25 19:52:06 EDT 2025 Mon Jul 21 06:01:08 EDT 2025 Tue Jul 01 01:24:42 EDT 2025 Fri Feb 21 02:40:57 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Vitreous opacities YAG laser vitreolysis Floaters ablation Vitreous floaters |
Language | English |
License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c426t-4e8b35ec7416cc2993b00a35fda6707dbc0ae681db05545015bf1e3f4535b57c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1007/s10792-023-02858-0 |
PMID | 37665493 |
PQID | 2902162750 |
PQPubID | 37279 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10724304 proquest_miscellaneous_2860617250 proquest_journals_2902162750 pubmed_primary_37665493 crossref_primary_10_1007_s10792_023_02858_0 springer_journals_10_1007_s10792_023_02858_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationSubtitle | The International Journal of Clinical Ophthalmology and Visual Sciences |
PublicationTitle | International ophthalmology |
PublicationTitleAbbrev | Int Ophthalmol |
PublicationTitleAlternate | Int Ophthalmol |
PublicationYear | 2023 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Schulz-Key, Carlsson, Crafoord (CR5) 2011; 89 Katsanos, Tsaldari, Gorgoli, Lalos, Asproudis (CR14) 2020; 37 Liu, Wang, Zhao (CR27) 2020; 20 Stites, Terr (CR30) 1991 Hahn, Schneider, Tabandeh, Wong, Emerson (CR20) 2017; 135 Fleisher, Ferrell, Mcgahan (CR31) 1992; 33 Huang, Weng, Chen, Chang (CR18) 2018; 49 Bergstrom, Czyz (CR3) 2018 Lin, Li, Zhang, Hui, Moutari, Pazo (CR13) 2022; 11 Koo, Haddock, Bhardwaj, Fortun (CR17) 2017; 101 Bhattacherjee, Henderson (CR33) 1987; 6 CR10 Noristani, Schultz, Dick (CR21) 2016; 26 CR32 Delaney, Oyinloye, Benjamin (CR28) 2002; 16 Freyler, Arnfelser, Weiss (CR29) 1976; 199 Little, Jack (CR26) 1986; 224 Rheaume, Vavvas (CR2) 2010; 25 Mason, Albert, Feist (CR7) 2014; 34 Shah, Heier (CR12) 2017; 135 de Vries, Faraj, Gerbrandy, Hulsman (CR25) 2022; 15 Wagle, Lim, Yap, Neelam, Au Eong (CR4) 2011; 152 Sebag, Yee, Wa (CR8) 2014; 34 Tan, Mura, Oberstein, Bijl (CR9) 2011; 151 O'Day, Cugley, Chen, Fabinyi (CR16) 2018; 46 Schulz-Key, Carlsson, Crafoord (CR6) 2015; 89 Cowan, Khine, Chopra, Fazio, Francis (CR15) 2015; 159 Shields, Cheng, Ruby, Williams, Wolfe (CR23) 2021; 52 Vandorselaer, Van De Velde, Tassignon (CR11) 2001; 280 Garcia, Orduna Magan, Alvarez-Peregrina, Villa-Collar, Sanchez-Tena (CR24) 2021 Shields, Cheng, Wolfe (CR22) 2021; 128 Sebag (CR1) 2002; 22 Sun, Lee, Chen (CR19) 2017; 8 DP Stites (2858_CR30) 1991 KH Huang (2858_CR18) 2018; 49 RA Shields (2858_CR22) 2021; 128 MA Rheaume (2858_CR2) 2010; 25 BG Garcia (2858_CR24) 2021 AM Wagle (2858_CR4) 2011; 152 X Liu (2858_CR27) 2020; 20 R Noristani (2858_CR21) 2016; 26 HS Tan (2858_CR9) 2011; 151 2858_CR10 2858_CR32 YM Delaney (2858_CR28) 2002; 16 J Sebag (2858_CR8) 2014; 34 IT Sun (2858_CR19) 2017; 8 RA Shields (2858_CR23) 2021; 52 R O'Day (2858_CR16) 2018; 46 T Vandorselaer (2858_CR11) 2001; 280 R Bergstrom (2858_CR3) 2018 EH Koo (2858_CR17) 2017; 101 S Schulz-Key (2858_CR5) 2011; 89 P Bhattacherjee (2858_CR33) 1987; 6 P Hahn (2858_CR20) 2017; 135 JO Mason (2858_CR7) 2014; 34 CP Shah (2858_CR12) 2017; 135 LN Fleisher (2858_CR31) 1992; 33 S Schulz-Key (2858_CR6) 2015; 89 J Sebag (2858_CR1) 2002; 22 A Katsanos (2858_CR14) 2020; 37 H Freyler (2858_CR29) 1976; 199 T Lin (2858_CR13) 2022; 11 LA Cowan (2858_CR15) 2015; 159 E de Vries (2858_CR25) 2022; 15 HL Little (2858_CR26) 1986; 224 |
References_xml | – volume: 135 start-page: 973 year: 2017 end-page: 976 ident: CR20 article-title: Reported complications following laser vitreolysis publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.2477 – volume: 151 start-page: 995 year: 2011 end-page: 998 ident: CR9 article-title: Safety of vitrectomy for floaters publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.01.005 – volume: 159 start-page: 138 year: 2015 end-page: 143 ident: CR15 article-title: Refractory open-angle glaucoma after neodymium–yttrium–aluminum–garnet laser lysis of vitreous floaters publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2014.10.006 – year: 1991 ident: CR30 publication-title: Basic Human Immunology – volume: 26 start-page: e149 year: 2016 end-page: e151 ident: CR21 article-title: Cataract formation after YAG laser vitreolysis: importance of femtosecond laser anterior capsulotomies in perforated posterior capsules publication-title: Eur J Ophthalmol doi: 10.5301/ejo.5000854 – volume: 152 start-page: 60 year: 2011 end-page: 65-e1 ident: CR4 article-title: Utility values associated with vitreous floaters publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.01.026 – volume: 16 start-page: 21 year: 2002 ident: CR28 article-title: Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters publication-title: Eye doi: 10.1038/sj.eye.6700026 – volume: 25 start-page: 295 year: 2010 end-page: 302 ident: CR2 article-title: Pharmacologic vitreolysis publication-title: Semin Ophthalmol doi: 10.3109/08820538.2010.518865 – ident: CR10 – volume: 89 start-page: 159 year: 2011 end-page: 165 ident: CR5 article-title: Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2009.01682.x – volume: 22 start-page: 1 year: 2002 end-page: 3 ident: CR1 article-title: Is pharmacologic vitreolysis brewing? publication-title: Retina doi: 10.1097/00006982-200202000-00001 – volume: 224 start-page: 240 year: 1986 end-page: 246 ident: CR26 article-title: Q-switched neodymium: YAG laser surgery of the vitreous publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/BF02143063 – volume: 89 start-page: 159 year: 2015 end-page: 165 ident: CR6 article-title: Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2009.01682.x – volume: 128 start-page: 616 year: 2021 ident: CR22 article-title: Iatrogenic vitreous hemorrhage, subretinal hemorrhage, and branch retinal vein occlusion after YAG laser vitreolysis for symptomatic vitreous floaters publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.10.026 – volume: 8 start-page: 321 year: 2017 end-page: 325 ident: CR19 article-title: Rapid cataract progression after Nd:YAG vitreolysis for vitreous floaters: a case report and literature review publication-title: Case Rep Ophthalmol doi: 10.1159/000477159 – volume: 11 start-page: 201 year: 2022 end-page: 214 ident: CR13 article-title: The efficacy and safety of YAG laser vitreolysis for symptomatic vitreous floaters of complete PVD or non-PVD publication-title: Ophthalmol Ther doi: 10.1007/s40123-021-00422-6 – volume: 46 start-page: 956 year: 2018 end-page: 958 ident: CR16 article-title: Bilateral posterior capsule injury after Nd:YAG laser vitreolysis: unintended consequence of floaters treatment publication-title: Clin Exp Ophthalmol doi: 10.1111/ceo.13190 – volume: 6 start-page: 929 year: 1987 end-page: 934 ident: CR33 article-title: Inflammatory responses to intraocularly injected interleukin 1 publication-title: Curr Eye Res doi: 10.3109/02713688709034861 – volume: 34 start-page: 1055 year: 2014 end-page: 1061 ident: CR7 article-title: Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters publication-title: Retina doi: 10.1097/IAE.0000000000000063 – volume: 101 start-page: 709 year: 2017 end-page: 711 ident: CR17 article-title: Cataracts induced by neodymium–yttrium–aluminium–garnet laser lysis of vitreous floaters publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2016-309005 – volume: 49 start-page: e214 year: 2018 end-page: e217 ident: CR18 article-title: Iatrogenic posterior lens capsule rupture and subsequent complications due to Nd:YAG laser vitreolysis for vitreous floaters: a case report publication-title: Ophthalmic Surg Lasers Imaging Retina doi: 10.3928/23258160-20181101-21 – year: 2018 ident: CR3 publication-title: Vitreous floaters – volume: 135 start-page: 918 year: 2017 end-page: 923 ident: CR12 article-title: YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.2388 – volume: 52 start-page: 610 year: 2021 end-page: 613 ident: CR23 article-title: Retinal complications after yttrium–aluminum–garnet laser vitreolysis for vitreous floaters publication-title: Ophthal Surg Lasers Imaging Retina doi: 10.3928/23258160-20211014-02 – volume: 199 start-page: 267 year: 1976 end-page: 275 ident: CR29 publication-title: Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie doi: 10.1007/BF00417297 – volume: 33 start-page: 2120 year: 1992 end-page: 2127 ident: CR31 article-title: Synergistic uveitic effects of tumor necrosis factor-alpha and interleukin-1 beta publication-title: Invest Ophthalmol Vis – year: 2021 ident: CR24 article-title: Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters publication-title: Eur J Ophthalmol doi: 10.1177/11206721211008036 – volume: 280 start-page: 15 year: 2001 end-page: 19 ident: CR11 article-title: Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters publication-title: Bull Soc Belge Ophtalmol – volume: 34 start-page: 1062 year: 2014 end-page: 1068 ident: CR8 article-title: Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile publication-title: Retina doi: 10.1097/IAE.0000000000000065 – ident: CR32 – volume: 37 start-page: 1319 year: 2020 end-page: 1327 ident: CR14 article-title: Safety and efficacy of YAG laser vitreolysis for the treatment of vitreous floaters: an overview publication-title: Adv Ther doi: 10.1007/s12325-020-01261-w – volume: 15 start-page: e248937 year: 2022 ident: CR25 article-title: Secondary open-angle glaucoma following YAG-laser vitreolysis publication-title: BMJ Case Rep doi: 10.1136/bcr-2022-248937 – volume: 20 start-page: 157 year: 2020 ident: CR27 article-title: Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report publication-title: BMC Ophthalmol doi: 10.1186/s12886-020-01428-7 – volume: 151 start-page: 995 year: 2011 ident: 2858_CR9 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.01.005 – volume: 34 start-page: 1055 year: 2014 ident: 2858_CR7 publication-title: Retina doi: 10.1097/IAE.0000000000000063 – volume: 26 start-page: e149 year: 2016 ident: 2858_CR21 publication-title: Eur J Ophthalmol doi: 10.5301/ejo.5000854 – volume: 159 start-page: 138 year: 2015 ident: 2858_CR15 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2014.10.006 – ident: 2858_CR32 doi: 10.1016/0167-5699(88)91200-5 – volume: 52 start-page: 610 year: 2021 ident: 2858_CR23 publication-title: Ophthal Surg Lasers Imaging Retina doi: 10.3928/23258160-20211014-02 – volume: 280 start-page: 15 year: 2001 ident: 2858_CR11 publication-title: Bull Soc Belge Ophtalmol – volume: 89 start-page: 159 year: 2011 ident: 2858_CR5 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2009.01682.x – volume: 135 start-page: 973 year: 2017 ident: 2858_CR20 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.2477 – volume: 22 start-page: 1 year: 2002 ident: 2858_CR1 publication-title: Retina doi: 10.1097/00006982-200202000-00001 – volume: 16 start-page: 21 year: 2002 ident: 2858_CR28 publication-title: Eye doi: 10.1038/sj.eye.6700026 – volume: 20 start-page: 157 year: 2020 ident: 2858_CR27 publication-title: BMC Ophthalmol doi: 10.1186/s12886-020-01428-7 – volume-title: Basic Human Immunology year: 1991 ident: 2858_CR30 – volume: 37 start-page: 1319 year: 2020 ident: 2858_CR14 publication-title: Adv Ther doi: 10.1007/s12325-020-01261-w – volume: 25 start-page: 295 year: 2010 ident: 2858_CR2 publication-title: Semin Ophthalmol doi: 10.3109/08820538.2010.518865 – ident: 2858_CR10 – year: 2021 ident: 2858_CR24 publication-title: Eur J Ophthalmol doi: 10.1177/11206721211008036 – volume: 152 start-page: 60 year: 2011 ident: 2858_CR4 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.01.026 – volume: 199 start-page: 267 year: 1976 ident: 2858_CR29 publication-title: Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie doi: 10.1007/BF00417297 – volume: 33 start-page: 2120 year: 1992 ident: 2858_CR31 publication-title: Invest Ophthalmol Vis – volume: 6 start-page: 929 year: 1987 ident: 2858_CR33 publication-title: Curr Eye Res doi: 10.3109/02713688709034861 – volume-title: Vitreous floaters year: 2018 ident: 2858_CR3 – volume: 89 start-page: 159 year: 2015 ident: 2858_CR6 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2009.01682.x – volume: 34 start-page: 1062 year: 2014 ident: 2858_CR8 publication-title: Retina doi: 10.1097/IAE.0000000000000065 – volume: 49 start-page: e214 year: 2018 ident: 2858_CR18 publication-title: Ophthalmic Surg Lasers Imaging Retina doi: 10.3928/23258160-20181101-21 – volume: 135 start-page: 918 year: 2017 ident: 2858_CR12 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.2388 – volume: 101 start-page: 709 year: 2017 ident: 2858_CR17 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2016-309005 – volume: 15 start-page: e248937 year: 2022 ident: 2858_CR25 publication-title: BMJ Case Rep doi: 10.1136/bcr-2022-248937 – volume: 8 start-page: 321 year: 2017 ident: 2858_CR19 publication-title: Case Rep Ophthalmol doi: 10.1159/000477159 – volume: 46 start-page: 956 year: 2018 ident: 2858_CR16 publication-title: Clin Exp Ophthalmol doi: 10.1111/ceo.13190 – volume: 11 start-page: 201 year: 2022 ident: 2858_CR13 publication-title: Ophthalmol Ther doi: 10.1007/s40123-021-00422-6 – volume: 128 start-page: 616 year: 2021 ident: 2858_CR22 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.10.026 – volume: 224 start-page: 240 year: 1986 ident: 2858_CR26 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/BF02143063 |
SSID | ssj0009796 |
Score | 2.3172674 |
Snippet | Purpose
To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.
Methods
Thirty-six New Zealand rabbits were divided... To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Thirty-six New Zealand rabbits were divided as follows:... PurposeTo evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.MethodsThirty-six New Zealand rabbits were divided as... To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.PURPOSETo evaluate the safety of yttrium-aluminum-garnet... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 4585 |
SubjectTerms | Ablation Abnormalities Aluminum Aqueous humour Complications Cytokines Eye Eye lens IL-1β Inflammation Interleukin 8 Interleukins Intraocular pressure Lasers Leukocytes (neutrophilic) Medicine Medicine & Public Health Ophthalmology Optical Coherence Tomography Original Paper Postoperative Rabbits Safety Semiconductor lasers Tissue analysis Transmission electron microscopy Tumor necrosis factor-TNF Tumor necrosis factor-α YAG lasers Yttrium |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZgSBMvCNiAwEBG2huzcGM7dnlBE2JMSONlm1SeMtu5iL4kpc2Q-PfcOW6rMsGzHdm-O_u--M7fMXYcqrYK4KaigWkjtFWtCNE7PAzjBKTXlVP0OPniW3V-rb_OzCxfuK1yWuX6TEwHddNHuiN_X07RGxGlrvy4-CmoahRFV3MJjfvsAVGXkVXbmd2S7tpUn4te7Ahj5SQ_mslP5yzlXZYUxXTGCbnrmO6gzbtJk39FTpNDOnvMHmUkyU9H1T9h96B7yvYvcqz8gN1c-haG37xv-ffTLxxRMiz5r_mwhD7RkHCEq3xOo_QpF5UPSQerD9xnohL6dEHEGwsY-cH5TgL6Ibs--3z16Vzkegoioh8ehAYXlIFIICxG9EMK95xXpm18ZaVtQpQeKgSwQSLIMAgUQjsB1WqjTDA2qmdsr-s7eMF4bKZQAsKvMjo9sTE0Tjk0hwa89bo1BXu3Fma9GGkz6i1BMom-RtHXSfS1LNjRWt513kKreqvwgr3dNKPxU0TDd9DfYh9XJQhGfZ6P6tkMhydnhT-_qmBuR3GbDkSsvdvSzX8kgm2cYKmV1AU7Wet4O69_L-Pl_5fxij2kWvVjLswR2xuWt_AaEc0Q3iSz_QO3FfTF priority: 102 providerName: ProQuest |
Title | Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications |
URI | https://link.springer.com/article/10.1007/s10792-023-02858-0 https://www.ncbi.nlm.nih.gov/pubmed/37665493 https://www.proquest.com/docview/2902162750 https://www.proquest.com/docview/2860617250 https://pubmed.ncbi.nlm.nih.gov/PMC10724304 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7aBEovJenTbWK20FsrkLVP9WYbO6ElprQ1OCd1dzUivkjGUQr595mVZBsn6aEX7WFn2dXMPr5lZr4F-ORUoRyaNMoxzSOheRE5bw1thn6AsRXK8JCcfDFT53PxbSEXHU1OyIW5578PKW46xEcmwdtopInoen4oB1yHZxrGarwj2NWp6pJiHm-3f_A8QJMPgyLveUabA2d6BC86pMiGrWmP4QmWL-HZRecLfwV_ftkC61tWFexyeMYIBeOa_V3Wa6wamhFGcJQtQy9VE2vK6kbH11-Z7YhIQtNVINZYYcv_zfYCzF_DfDr5PT6PuvcSIk_nbB0JNI5L9AFkeU_nDKc1Zbkscqt0rHPnY4uKAKqLCURIAgKuGCAvhOTSSe35GzgoqxLfAfN5igkSvEq8EQPtXW64IXPnaLUVhezB540ys1VLi5HtCJCD6jNSfdaoPot7cLLRd9YtkessSQleBI5kqv64rabJHTwWtsTqhmSMaiBWkHnbmmfbHe2Mii63vAdmz3BbgUCcvV9TLq8aAm0aYCJ4LHrwZWPj3bj-_Rvv_0_8AzwPb9O3sS8ncFCvb_CUEEzt-vBUL3QfDofT0WgWyrPL7xMqR5PZj5_9ZmLTd54M7wC-7fJB |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIgEXVL4DBYwEJ4jwxnHsrVShCihb2u2FVlpOqe04Yi_JspuC-qf4jZ1xkl0tFdx6jhMnM-OZ58zMM8Brm5WZ9XoYF35YxKkSZWyd0egM3cBzk2ZaUHPy-DgbnaZfJ3KyAX_6Xhgqq-x9YnDURe3oH_n7ZIjRiCh1-YfZz5hOjaLsan-ERmsWh_7iN27ZFrsHn1C_b5Jk__PJx1HcnSoQO4xGTZx6bYX0jqCIc-iNBVqeEbIsTKa4KqzjxmcI4yzHUCsxXNpy4EWZSiGtVE7gc2_ATQy8nDZ7aqJWJL8qnAdGHUKxVHzQNel0rXqK6jwTyppqqWO-HgivoNurRZp_ZWpDANzfgrsdcmV7randgw1f3Ydb4y43_wDOvpnSNxesLtn3vS8MUbmfs1_TZu7rQHvCEB6zKc1Sh9pX1gSdL3aY6YhR6NYZEX3MfMtHztYK3h_C6bVI-hFsVnXlnwBzxdAnHuFe4nQ6UM4WWmg0v8IbZdJSRvC2F2Y-a2k68hUhM4k-R9HnQfQ5j2C7l3feLdlFvjKwCF4tL-NiowyKqXx9jmN0FiAfjXncqmc5HXrqDDfbIgK9prjlACLyXr9STX8EQm98wSQVPI3gXa_j1Xv9-zOe_v8zXsLt0cn4KD86OD58BncSsr1Qh7MNm8383D9HNNXYF8GEGZxd95q5BC9eMU0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NTpp4QRs_sw0wEjxBtDSOYxcJocFWNsaqCZg0njLbuYi-JF2bgfav8dft7CStygRve44T2-fz3efc3WeAlyYtUoNqEOY4yMNE8iI0VisyhraPkU5SxV1x8vEoPThNPp-JsxX409XCuLTKziZ6Q51X1v0j34kH5I0cpW60U7RpESd7w_eTi9DdIOUird11Go2KHOHVbzq-zd4d7tFav4rj4f73jwdhe8NAaMkz1WGCynCB1sESa8kyc9JCzUWR61RGMjc20pgSpDMRuV1BrtMUfeRFIrgwQlpO370Dq9Kdinqw-mF_dPJ1Qfkr_e1grl4oFDLqtyU7beGedFmfsYuhKqHCaNkt3sC6N1M2_4rbenc4XId7LY5lu43ibcAKlvdh7biN1D-A82-6wPqKVQX7sfuJEUbHKfs1rqdYeRIURmCZjV0vlc-EZbXXgNlbpluaFPfqxNF-TLBhJ2dL6e8P4fRWZP0IemVV4hNgNh9gjAT-YquSvrQmV1yRMuaopU4KEcDrTpjZpCHtyBb0zE70GYk-86LPogC2O3ln7QaeZQt1C-DF_DFtPRdP0SVWl9RGpR4AujaPm-WZd0d2O6WjNw9ALS3cvIGj9V5-Uo5_enpvGmCc8CgJ4E23xotx_Xsam_-fxnNYo_2SfTkcHW3B3dipnk_K2YZePb3EpwStavOs1WEG57e9ba4Bm8g26A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+YAG+laser+vitreolysis+for+intraocular+tissues%3A+analysis+of+postoperative+complications&rft.jtitle=International+ophthalmology&rft.au=Liu%2C+Jiannan&rft.au=Wang%2C+Hao&rft.au=Gu%2C+Wei&rft.au=Zhao%2C+Tingting&rft.date=2023-12-01&rft.issn=1573-2630&rft.eissn=1573-2630&rft.volume=43&rft.issue=12&rft.spage=4585&rft.epage=4593&rft_id=info:doi/10.1007%2Fs10792-023-02858-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10792_023_02858_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-2630&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-2630&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-2630&client=summon |